PERCEPTIVE ADVISORS LLC 13D and 13G filings for Albireo Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2023-02-14 2:31 pm Sale |
2022-12-31 | 13G | Albireo Pharma, Inc. ALBO |
PERCEPTIVE ADVISORS LLC | 1,757,160 8.500% |
-602,979![]() (-25.55%) |
Filing |
2022-02-14 4:10 pm Unchanged |
2021-12-31 | 13G | Albireo Pharma, Inc. ALBO |
PERCEPTIVE ADVISORS LLC | 2,360,139 12.200% |
0 (Unchanged) |
Filing |
2021-02-16 3:36 pm Purchase |
2020-12-31 | 13G | Albireo Pharma, Inc. ALBO |
PERCEPTIVE ADVISORS LLC | 2,360,139 12.400% |
655,809![]() (+38.48%) |
Filing |